Kyle J Edmunds, Alyssa A Pandos, Isabella Hoang, Gabriella M Mamlouk, Alice Motovylyak, Sarah R Lose, Sanjay Asthana, Matthew Stremlau, Sterling C Johnson, Henriette van Praag, Ozioma C Okonkwo
{"title":"在阿尔茨海默病高风险人群中,BDNF表达介导言语学习和记忆。","authors":"Kyle J Edmunds, Alyssa A Pandos, Isabella Hoang, Gabriella M Mamlouk, Alice Motovylyak, Sarah R Lose, Sanjay Asthana, Matthew Stremlau, Sterling C Johnson, Henriette van Praag, Ozioma C Okonkwo","doi":"10.1002/dad2.70062","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study examined whether sex differences in verbal learning and memory (VLM) are mediated by plasma brain-derived neurotrophic factor (BDNF) expression.</p><p><strong>Methods: </strong>In a sample of <i>n</i> = 201 participants (63.81 ± 6.04 years, 66.2% female, 65.7% family history of Alzheimer's disease [AD], 38% apolipoprotein E [<i>APOE</i>] ε4<i>+</i>) from the Wisconsin Registry for Alzheimer's Prevention, VLM was measured using trials 3 through 5 and delayed recall from the Rey Auditory Verbal Learning Test. Plasma BDNF was measured using a Human BDNF Quantikine Immunoassay. Mediation analysis used bootstrapping, and stratified mediation models tested the conditional dependence of <i>APOE</i> ε4 carriage.</p><p><strong>Results: </strong>BDNF partially mediated the sex-VLM relationship (β = -0.07; 95% confidence interval [CI]: -0.18, -0.01). Female <i>APOE</i> ε4 carriers had higher VLM scores (β = -0.53; <i>p</i> = 0.03), while female non-carriers had both higher BDNF levels (β = -0.68; <i>p</i> < 0.01) and VLM scores (β = -1.06; <i>p</i> < 0.01); BDNF was again a significant mediator (β = -0.18; 95% CI: -0.37, -0.05).</p><p><strong>Discussion: </strong>This study found that circulating BDNF mediates higher verbal memory scores in females-particularly in <i>APOE</i> ε4 non-carriers.</p><p><strong>Highlights: </strong>Sex differences in verbal learning and memory (VLM) were mediated by plasma brain-derived neurotrophic factor (BDNF) levels.Women exhibited higher VLM scores and plasma BDNF levels compared to men.The protective effect of BDNF in women was attenuated by apolipoprotein E ε4 carriage.Findings suggest sex-specific mechanisms against verbal memory decline in aging.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"17 1","pages":"e70062"},"PeriodicalIF":4.0000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11736622/pdf/","citationCount":"0","resultStr":"{\"title\":\"BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease.\",\"authors\":\"Kyle J Edmunds, Alyssa A Pandos, Isabella Hoang, Gabriella M Mamlouk, Alice Motovylyak, Sarah R Lose, Sanjay Asthana, Matthew Stremlau, Sterling C Johnson, Henriette van Praag, Ozioma C Okonkwo\",\"doi\":\"10.1002/dad2.70062\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>This study examined whether sex differences in verbal learning and memory (VLM) are mediated by plasma brain-derived neurotrophic factor (BDNF) expression.</p><p><strong>Methods: </strong>In a sample of <i>n</i> = 201 participants (63.81 ± 6.04 years, 66.2% female, 65.7% family history of Alzheimer's disease [AD], 38% apolipoprotein E [<i>APOE</i>] ε4<i>+</i>) from the Wisconsin Registry for Alzheimer's Prevention, VLM was measured using trials 3 through 5 and delayed recall from the Rey Auditory Verbal Learning Test. Plasma BDNF was measured using a Human BDNF Quantikine Immunoassay. Mediation analysis used bootstrapping, and stratified mediation models tested the conditional dependence of <i>APOE</i> ε4 carriage.</p><p><strong>Results: </strong>BDNF partially mediated the sex-VLM relationship (β = -0.07; 95% confidence interval [CI]: -0.18, -0.01). Female <i>APOE</i> ε4 carriers had higher VLM scores (β = -0.53; <i>p</i> = 0.03), while female non-carriers had both higher BDNF levels (β = -0.68; <i>p</i> < 0.01) and VLM scores (β = -1.06; <i>p</i> < 0.01); BDNF was again a significant mediator (β = -0.18; 95% CI: -0.37, -0.05).</p><p><strong>Discussion: </strong>This study found that circulating BDNF mediates higher verbal memory scores in females-particularly in <i>APOE</i> ε4 non-carriers.</p><p><strong>Highlights: </strong>Sex differences in verbal learning and memory (VLM) were mediated by plasma brain-derived neurotrophic factor (BDNF) levels.Women exhibited higher VLM scores and plasma BDNF levels compared to men.The protective effect of BDNF in women was attenuated by apolipoprotein E ε4 carriage.Findings suggest sex-specific mechanisms against verbal memory decline in aging.</p>\",\"PeriodicalId\":53226,\"journal\":{\"name\":\"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring\",\"volume\":\"17 1\",\"pages\":\"e70062\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-01-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11736622/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/dad2.70062\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease.
Introduction: This study examined whether sex differences in verbal learning and memory (VLM) are mediated by plasma brain-derived neurotrophic factor (BDNF) expression.
Methods: In a sample of n = 201 participants (63.81 ± 6.04 years, 66.2% female, 65.7% family history of Alzheimer's disease [AD], 38% apolipoprotein E [APOE] ε4+) from the Wisconsin Registry for Alzheimer's Prevention, VLM was measured using trials 3 through 5 and delayed recall from the Rey Auditory Verbal Learning Test. Plasma BDNF was measured using a Human BDNF Quantikine Immunoassay. Mediation analysis used bootstrapping, and stratified mediation models tested the conditional dependence of APOE ε4 carriage.
Results: BDNF partially mediated the sex-VLM relationship (β = -0.07; 95% confidence interval [CI]: -0.18, -0.01). Female APOE ε4 carriers had higher VLM scores (β = -0.53; p = 0.03), while female non-carriers had both higher BDNF levels (β = -0.68; p < 0.01) and VLM scores (β = -1.06; p < 0.01); BDNF was again a significant mediator (β = -0.18; 95% CI: -0.37, -0.05).
Discussion: This study found that circulating BDNF mediates higher verbal memory scores in females-particularly in APOE ε4 non-carriers.
Highlights: Sex differences in verbal learning and memory (VLM) were mediated by plasma brain-derived neurotrophic factor (BDNF) levels.Women exhibited higher VLM scores and plasma BDNF levels compared to men.The protective effect of BDNF in women was attenuated by apolipoprotein E ε4 carriage.Findings suggest sex-specific mechanisms against verbal memory decline in aging.
期刊介绍:
Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.